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A systematic review was conducted to assess the level of evidence for integrative health care research. We searched PubMed, Allied
and Complementary Medicine (AMED), BIOSIS Previews, EMBASE, the entire Cochrane Library, MANTIS, Social SciSearch,
SciSearch Cited Ref Sci, PsychInfo, CINAHL, and NCCAM grantee publications listings, from database inception to May 2009, as
wellassearchesofthe“grayliterature.”AvailablestudiespublishedinEnglishlanguagewereincluded.Threeindependentreviewers
rated each article and assessed the methodological quality of studies using the Scottish Intercollegiate Guidelines Network (SIGN
50). Our search yielded 11,891 total citations but 6 clinical studies, including 4 randomized, met our inclusion criteria. There
are no available systematic reviews/meta-analyses published that met our inclusion criteria. The methodological quality of the
included studies was assessed independently using quality checklists of the SIGN 50. Only a small number of RCTs and CCTs with
a limited number of patients and lack of adequate control groups assessing integrative health care research are available. These
studies provide limited evidence of eﬀective integrative health care on some modalities. However, integrative health care regimen
appears to be generally safe.
1.Introduction
In the United States, “institutional integrative health care
(aka integrative medicine) is being developed in a highly
individualistic manner (page 3)” [1]. Much of this literature
refers to integrating CAM into institutional health systems
and involves bringing CAM providers into conventional
health centers [2]. However, there is another approach to
integrativehealthcareemergingwithintheCAMcommunity
itself, the insurance industry and with what is termed by one
writer as the “CAM entrepreneurs” [2, 3].
There are various deﬁnitions and a diversity of terminol-
ogyofintegrativehealthcare[4].Maizesetal.deﬁnetheterm
“integrative medicine” as “medicine that reemphasizes the
relationship between patient and physician, and integrates
the best of complementary and alternative medicine with
the best of conventional medicine” [5]. Boon et al.’s [4]
study on the working deﬁnition for integrative health care
deﬁnes “integrative health care” as the combination of an
interdisciplinary,nonhierarchicalblendingofbothCAMand
conventional medicine that employs a collaborative team
approach guided by consensus building, mutual respect,
and a shared vision of health through a partnership of
patient and practitioners to treat the whole person by
synergistically combining therapies and services in a manner
that exceeds the collective eﬀect of the individual practice2 Evidence-Based Complementary and Alternative Medicine
[4]. Interestingly, at the prestigious IOM conference on
integrative health care no formal deﬁnition emerged [6].
Therefore, the deﬁnition of integrative health care can
range from simply incorporating CAM into conventional
medicine to the notion that integrative health care con-
stitutes a new form of medical practice. Stumpf, Shapiro,
and Hardy refer to the malleable deﬁnitions of integrative
health care as “one ﬁrst step towards understanding the
phenomenon.” However, a deﬁnition is more likely to
emerge from key issues that are shaping the future of
integrative medicine. That is, bilateral integrative medicine
more resembles assimilation of CAM by biomedicine than
true acculturation [7].
It seems that regardless of the deﬁnitions, health care
practitioners and policy makers have increasingly recognized
thatpatientsareusingintegrativehealthcaretoimprovetheir
wellness and treat illness [8]. Thus, for this paper, a guiding
principle to the deﬁnition of integrative health care research is
thestudyoftheincorporation ofCAMwithbiomedicine asa
collaborativeandintegralpartofthehealthcaresystem.That
is, the integration of conventional (allopathic) medicine and
CAM, involving shared management of the patient, shared
patient care, shared practice guidelines, and shared common
values and goals to treat the well-being of the whole person.
There is preliminary theoretical and empirical data to
support that integrative health care is not equivalent to
CAM [9, 10]. However, the diversity of deﬁnitions, the
ranges in levels of integration, and the degree of integration
between CAM and biomedicine poses challenges to the
practice, research, education, and policy/guideline decision
and development in this evolving ﬁeld.
We posit that incorporation of CAM into conventional
medicine without a joint management does not constitute
integrative health care. In fact, the use of CAM as an
adjunctive treatment to conventional care without a unifying
paradigm or joint management may lead to worse outcomes
because the selected CAM modality may adversely interact
with conventional modality, and vice versa. In essence,
integrative health care combines the best products and
practices of CAM and conventional health care to optimize
the body’s natural healing processes [5, 11].
The purpose of this paper is to review and summa-
rize literature on Randomized controlled trial (RCT) and
Controlled clinical trial (CCT), and systematic reviews
on integrative health care as deﬁned above and to make
recommendations for future research on this topic.
2. Methods
We conducted a systematic literature review using a web-
based,secure,systematicreviewmanagementprogramcalled
TrialStat SRS 4.0 ( c Copyright 2003–2009 Mobius Analytics
Inc, Ottawa, Ontario). TrialStat automates article progres-
sion and management, eliminates data transcription and
reduces data collation work at the end of a review. This
approach diﬀers from conventional systematic literature
review because it allows researchers to deliver results faster
with improved accuracy and quality, providing a complete
audit trail of all changes made in the systematic review. We
searched the following databases from 1965 to Sept 2007:
Pubmed, Allied and Complementary Medicine (AMED),
BIOSIS Previews, EMBASE, the entire Cochrane Library,
MANTIS, Social SciSearch, SciSearch Cited Ref Sci, Psych-
Info, CINAHL, and NCCAM grantee publications listings.
For the initial search, gray literature was searched using
ProQuest Dissertations and Theses, and Google Scholar
From our search strategy the keywords are identiﬁed in
Table 3.
AnupdatedsecondarysearchwasconductedinMay2009
during manuscript development to insure that all articles
meeting the inclusion/exclusion criteria using the original
search terms were included. In addition, hand searches and
reference tracking were also performed, and the citation list
was assessed for comprehensiveness by content experts.
2.1. Inclusion and Exclusion Criteria. Our initial search
terms were Integrat∗ and Medicine; Integrat∗ and Health∗
(for healthcare); multidisciplinary care; complementary or
alternative and conventional medicine or health care; and
delivery of health care and integrat∗.
Three investigators (RK, IC, and AH) independently
screened titles and abstracts for relevance based on the
inclusion criteria for this paper. Any disagreements about
including a study were resolved through discussion and
consensus. To avoid any misinterpretation, we excluded
articles in languages other than English.
This paper reports only on the RCT’s, CCTs, and meta-
analysis that passed our second level review screening. How-
ever, we have collected articles on practice models, models of
integration, program evaluation, observational studies, cost-
eﬀectiveness, healthcare utilization, and so forth, which will
be reported at a future date. The initial search retrieved all
the above articles which were coded into their respective
categories of study design. These were included in the
bibliography but excluded from formal evaluation in this
paper (see Figure 1).
Articles were included in this paper if they met the
following criteria: (1) involved human subjects; (2) clinical
study designs, including clinical controlled trials (including
RCTs) and systematic reviews or meta-analysis involved
with integrative health care research; and (3) integrative
health care treatment as deﬁned by the authors of this
paper (including at least one modality from CAM and
one modality from conventional medicine and they are
combined using an integrative healthcare paradigm). We
limited studies to those published in the English language.
We also excluded studies with one of the following criteria:
(1) did not present original data or an analysis of origi-
nal data (i.e., commentaries, editorials, or expert opinion
pieces); (2) were published in other media or in incomplete
formats (i.e., abstracts, conference proceedings, posters, or
web postings); (3) exclusively CAM without integration
with conventional medicine; (4) use of CAM as adjunctive
therapy to conventional medicine without incorporating
an integrative health care paradigm in the design of the
study; (5) studies that tested herbs and supplements; and (6)
not applicable to Western health care setting. Also, articlesEvidence-Based Complementary and Alternative Medicine 3
11591 records identiﬁed through
database searching and through
other sources Sept 1, 2007
11231 excluded
studies
660 full text articles assessed
for eligibility
Categories for other studies
included in the bibliography
Categories for excluded studies
11891 records screened
20 studies
included in
qualitative
synthesis
126 RCTs
21 systematic reviews
￿ 5 guidelines
￿ 10 position consensus statements
￿ 21 reviews
￿ 30 descriptive studies
￿ 34 program evaluations
￿ 38 business models
￿ 75 observation studies/case studies
￿ 98 conceptual/philosophical
￿ 121 strategies for integrative health care
￿ 157 practice mode studies
￿ 6 database
￿ 14 conference proceedings
￿ 56 editorial
￿ 107 animal study
￿ 10859 not relevant
￿ 182 duplicates
￿ 66 not applicable to
western health care
setting
￿ 4 full text articles
irretrievable
￿ 5 studies that tested
herbs/supplements
￿ 52 adjunctive therapy
studies
￿ 7 basic science/mechanistic studies
￿ 11 cost eﬀectiveness/utilization studies
300 records identiﬁed through database
and through other sources searching
Sept 1, 2007–May, 2009
106 RCTs excluded
21 systematic reviews excluded
Categories of excluded
studies
Figure 1: Systematic review ﬂow chart.
on integrated care pathways, integrated review, integrated
managed health system (i.e., electronic patient records,
integrateddeliverysystems/networksorhealthcaredelivery),
clinical integration, integrated case management, integrated
analysis, exclusively CAM without conventional medicine
integration,exclusivelyconventionalmedicinewithoutCAM
integration, scholarship of integration, integration into a
curriculumforeducation,integratingtheoryofconventional
medicine, integrated approach to concepts or integrating
a single conventional medicine therapy to another, not
applicable to western health care setting, and legalities or
regulation of integration were excluded as “not relevant”.
This paper did not involve human or nonhuman experi-
mentation and was exempt from Institutional Review Board
(IRB) approval.
2.2. Methodological Assessment Process and Quality Rating.
The methodological quality of the included studies was
assessed independently by the reviewers (RK, IC, and AH).
Each article was evaluated by type of study design and
quality.
RCTs, CCTs and meta-analysis were evaluated for study
quality and study design bias using the Scottish Intercol-
legiate Guidelines Network (SIGN) checklists [12, 13] (see
Table 1).
Also, there were independent assessments of the quality
of the studies selected, and data extraction comprised
descriptive information of the study population, the types
of interventions, and the relevant outcome measurements
and diﬀerences in ratings were resolved by reconciliation,
discussion, and consensus. The outcome measures in each
article were extracted and a determination was made regard-
ing the direction of evidence for each study as strong, mixed,
weak, or inconclusive (see Table 4). Controlled clinical trials
(CCTs) (i.e., nonrandomized, pilot, single group, and other
small studies) were qualitatively discussed in this paper
regarding outcomes measures and study dropouts but not
formally scored for bias such as randomization and blinding
(see Table 4).
Total eﬀect size was not calculated due to the hetero-
geneity of the trials identiﬁed during the review phase. All
assessments were based on information provided in the
published manuscripts that met the inclusion criteria.4 Evidence-Based Complementary and Alternative Medicine
Table 1: SIGN checklist [1].
Section 1: Internal validity∗
Item Description
1.1 Study addresses appropriate, clearly focused question.
1.2 Treatment group assignment is randomized.
1.3 Adequate concealment method is used.
1.4 Subjects and investigators are kept “blind” about treatment allocation.
1.5 Treatment and control groups are similar at the start of the trial.
1.6 Only diﬀerence between groups is the treatment under investigation.
1.7 Outcomes are measured in a standard, valid, and reliable way.
1.8 What percentage of subjects in each treatment arm dropped out before the study was completed (i.e., record %)?
1.9 All subjects are analyzed in the groups to which they were randomly allocated (intention to treat analysis).
1.10 If the study is multisite, results are comparable for all sites.
Section 2: Overall assessment∗∗
How well was the study done to minimize bias? How valid is the study? Code ++, +, or −
∗Each item in Section 1 is to be evaluated using these criteria:
(i) Well covered
(ii) Adequately addressed
(iii) Poorly addressed
(iv) Not addressed (i.e., not mentioned, or indicates that this aspect was ignored)
(v) Not reported (i.e., mentioned, but insuﬃcient detail to allow assessment)
(vi) Not applicable
∗∗The overall assessment uses the following ratings.
++ All or most of the criteria have been fulﬁlled. Where they have not been fulﬁlled the conclusions of the study or review are thought
very unlikely to alter.
+ Some of the criteria have been fulﬁlled. Those criteria that have not been fulﬁlled or not adequately described are thought unlikely
to alter the conclusions.
− Few or no criteria fulﬁlled. The conclusions of the study are thought likely or very likely to alter.
2.3. Adverse Events Methodology and Reporting. Safety eval-
uation and adverse events reporting in all the RCTs were
conducted using a 100 point safety assessment scale (SAS-
CT) [14]. This scale has six major domains and the sub-
domains have diﬀerent weights according to their degree
of importance and rate of occurrence. Safety evaluation
and adverse events reporting in all the clinical studies was
assessed by two investigators (RK and IC) and checked for
consistency (see Table 2 for scoring information).
If all information required is presented in the text, tables,
or ﬁgures, full points are given. If anything had to be
extrapolated or added or half information is missing, half
points are given. However, whether or not a conclusion can
be drawn depends on the amount of information available
[15] (see Table 4 for SAS-CT scores).
3.StudySelection
Our initial search yielded 11,591 citations from database
inception to Sept 2007. An additional secondary search was
conducted to capture studies published from September
2007–May 2009. This secondary search yielded 300 citations
(see Figure 1).
4. Results on QualityAssessment and
Trial Homogeneity
Heterogeneity acrossstudies (i.e.,outcomes,population, and
the small number of studies per therapy) precluded formal
meta-analysis. Therefore, it was only possible to conduct a
descriptive analysis of the studies’ design (study validity and
bias) and outcomes reported.
Of the 20 studies included in the qualitative synthesis,
a total of 6 articles met the inclusion criteria of this paper.
Of these 6 trials, there were 4 RCTs for which data were
extracted in a standardized manner, and three independent
investigators assessed the methodologically quality of RCTs
using the (SIGN) checklist (see Table 1). Table 4 describes
the main study characteristics and summarizes the ﬁndings
of the 4 RCTs and 2 CCTs. The studies reviewed in this paper
could not be combined for a total eﬀect size because of the 4
RCTs, three (3) were conducted by the same research group
on the same population and heterogeneity across studies.
Using the SIGN 50, three of the 4 RCTs (75%) were rated
as high quality “++”. One or (25%) of the RCTs was rated
as neutral “+”, and no RCT was rated as low quality “−”.
Individual SIGN item scores are available on Table 5.Evidence-Based Complementary and Alternative Medicine 5
Table 2: SAS-CT Adverse Events Scoring.
The safety assessment score for controlled clinical trials (SAS-CT) consists of six major domains. Each domain and subgroup has diﬀerent
weightings according to its degree of important and rate of occurrence.
The maximum subscores of:
(i) adverse events deﬁnitely not related to the intervention (AEs-NR) and adverse drug reactions (ADRs) are 27 points,
(ii) serious adverse events deﬁnitely not related to the intervention (SAEs-NR) and serious adverse drug reactions (SADRs) are 13.5
points,
(iii) drop-outs due to AE/SAEs-NR and ADRs/ SADRs have a maximum subscore of 9.5 points each.
Total SAS-CT score per control clinical trial equals 100 points.
Quality is based on the degree of the importance of the subdomains.
The SAS-CT is separated into three quality levels:
(i) poor (0 < SAS-CT < 28)
(ii) medium (28 < SAS-CT < 68)
(iii) high quality safety reporting (68 < SAS-CT < 100)
5. DescriptiveResults: Effects of Interventions
5.1. Clinical Trials on Multidimensional Integrative Health
Care Interventions (n = 6). Six articles [16–21] that
were clinical trials of multidimensional integrative health
care interventions were obtained. These 6 studies included
four RCTs on integrative health care therapies to improve
cardiovascular risk and/or disease symptoms [16–19], and
two CCTs evaluating integrative health care therapies to
improve quality of life/life satisfaction in women with breast
cancer [20, 21]. Three of these RCTs were multiple reports
published from the same research team on similar topics
and populations—the eﬃcacy of Noetic therapies before
percutaneous intervention for unstable coronary syndromes
[16–18].
The Monitoring and Actualization of Noetic therapy
(MANTRA) clinical trials [16–18] examined the feasibility
and eﬃcacy of applying 4 Noetic therapies—stress relax-
ation, imagery, touch therapy, and prayer—to patients in the
setting of acute coronary interventions compared to usual
care.TheresultsoftwoMANTRAtrials,byKrucoﬀetal.[16,
17] were not statistically signiﬁcant for any treatment out-
comes comparisons. However, there was a reduction (25%–
30%) in absolute incidence of major adverse cardiovascular
events(i.e.,mortality,myocardialinfarction,congestiveheart
failure, and urgent or repeat revascularization) or adverse
clinical events in patients treated with any Noetic therapies
compared to usual care (control). Also, in the pilot study
of the 4 individual Noetic therapies, oﬀ-site prayer was
associated with the lowest absolute mortality in-hospital and
at 6 months [16]. The parallel randomization to 4 diﬀerent
Noetic therapies across 5 study arms limited the assessment
of possible synergy between therapies.
When the same research team examined the beneﬁcial
eﬀects of Noetic therapies on mood assessed by Visual
Analogue Scale (VAS) before percutaneous coronary inter-
vention for unstable coronary syndromes they found that of
the eight VAS scales on mood only one, [the VAS for worry],
yieldedsigniﬁcanteﬀects(P<. 05)inthestressmanagement,
imagery, and touch therapy groups compared to with usual
therapy [18].
The ﬁnal RCT on an integrative health care to improve
cardiovascular risk was based on multidimensional interven-
tion principles [19]. Using a relationship-centered, mind-
body approach (including mindfulness meditation, relax-
ation training, stress management, motivational techniques,
and health education and coaching) in supporting behavior
change, the study reported signiﬁcant improvements in the
10-year cardiovascular risk as measured by the Framingham
risk score (FRS) compared to usual care [19].
5.2. Two CCTs on the Choice of Care for Breast Cancer. Two
nonrandomizedstudies,byCarlssonetal.[20,21],compared
quality-of-life of women with breast cancer who were treated
with anthroposophic therapy (ABCW) after surgery for
breast cancer, an individually composed therapies consisting
of natural products, Iscador, diets, art therapy, eurhythmic
therapy, therapeutic massage, hydrotherapy, compared to
usual care.
Carlsson et al. [20] conducted their ﬁrst study to inves-
tigate the acceptability and feasibility of an anthroposophic
therapy (ABCW) after surgery for breast cancer cared to
usual care. They measured the diﬀerences in perceived
quality-of-life/life satisfaction and coping strategies between
the women receiving ABCW on entering the CCT compared
to usual care alone. There were three primary outcome
instruments used in this study: (1) the European orga-
nization for research and treatment of cancer quality-of-
life questionnaire core 30 (EORTC QLQ-C30), (2) the life
satisfaction questionnaire (LSQ), and (3) the diﬀerences
in coping measured by the mental adjustment to cancer
scale. The results found that women who choose ABCW
reported lower quality-of-life and a greater psychosocial
distress compared to the women receiving usual care on all
measures on entering the study (P<. 05). The dropout
rate was about 13% for the ABCW group and 7% for
the usual care group. The authors examined the possibility
that perhaps the women in the ABCW group, who choose
theirindividualisticcare,mighthavebeenmoreindependent
personalities in choosing in their decision of care compared
to the usual care group. A follow-up study reported that the6 Evidence-Based Complementary and Alternative Medicine
Table 3: Oﬃcial keywords as entered into the databases were as follows:
(i) (integrated or integrative) and medicine
(ii) (integrated or integrative) and health∗
(iii) multidisciplinary care and alternative medicine
(iv) multidisciplinary care and complementary medicine
(v) (complementary or alternative) and conventional and (medicine or healthcare)
(vi) delivery of healthcare and (integrated or integrative)
(vii) (integrated or integrative) and patient evaluation
(viii) (integration and medicine) and (complementary or alternative)
(ix) (complementary or alternative) and medicine and (mainstream or biomedicine or orthodox).
women in ABCW group showed more passive and anxious
coping on admission, but this decreased over time [22]. This
could be one explanation for the ABCW higher dropout rate.
A second study from the same team (2004) [21], found
that women with breast cancer who participated in a 6-
month CCT and 1 year follow-up reported a signiﬁcant
(P<. 05) increase quality-of-life/life satisfaction (EORTC
QLQ-C30 and LSQ) after ABCW treatment compared to
the usual care alone. A follow-up study on the same
population of women found that after 5 years, there were
improvements in overall quality of life and in emotional and
social functioning compared to admission for the women
who choose ABCW. For these women, improvements took
place between admission and 1 year, but not further on [23].
Table 4 summarizes the methodological details and
results of these clinical trials of multidimensional integrative
health care interventions.
6. Result Summary
Our initial search yielded 11,591 citations of which six (4
RCTs and 2 CCTs) [16–21] were trials of integrative health
care interventions. We found that cardiovascular health
and women’s health were the two most common topics in
integrativehealthcareresearch.Thetotalaverageageofadult
subjects for the trial articles reviewed in this paper was 51.16
years. The most recent article in this paper was published in
2006, the oldest article was published in 2001. There were no
studies on integrative pediatric care.
Four RCTs were scored on internal validity and method-
ological bias using the SIGN checklist. Three of the 4 RCTs
(75%) were rated as high quality “++”. One or (25%) of the
RCTs was rated as neutral “+”, and no RCT was rated as low
quality “−”. Half (50%) of the total clinical trials included
in this paper were unable to report eﬀectiveness of their
intervention (i.e., no outcome measures as positive) despite
suﬃcient power to do so.
Most of these studies reported limitations such as the
lack of credible controls for a placebo eﬀect, inadequate
assessment of long-term treatment beneﬁts, and insuﬃcient
sample size, it would be diﬃcult to generalize these ﬁndings.
Two studies failed to report information on adverse events
as required to be presented in the manuscript text, tables, or
ﬁgures, and therefore scored 0 on the SAS-CT (see Tables 4
and 5).
7. Discussion
Two major conclusions can be drawn from this paper.
The ﬁrst is that there is an increasing, and somewhat
extensive, body of literature with key terms Integrat∗
and Medicine; Integrat∗ and Health∗ (for healthcare);
multidisciplinary care; complementary or alternative and
conventional medicine or health care; and delivery of health
care and integrat∗. This search found over 10,000 articles.
However, a second conclusion is that there are very few
clinical controlled trials testing the eﬃcacy of integrative
health care. The large number of articles that were not
relevant to our paper included studies on combining con-
ventional services and alternative modalities without the
incorporation of a collaborative and integral partnership of
an integrated health care system. That is, the integration
of conventional (allopathic) medicine and CAM, involving
shared management of the patient, shared patient care,
shared practice guidelines, and shared common values and
goals to treat the well-being of the whole person. We found
that the lack of a taxonomy makes searching this ﬁeld very
diﬃcult.
This might reﬂect that this research topic is an emerging
ﬁeld. Like any emerging ﬁeld integrative health care faces the
problem of how to deﬁne and operationalize itself. That is,
transforming the concepts into empirical and measurableen-
tities. According to Maizes and Caspi, Integrative Health
Care “requires a shift from the “ﬁxing” paradigm that has
been central to biomedicine (page 148)”. More importantly,
it “shifts the paradigm from sickness to health, keeps the
patient in the central focus of care, and multiplies the
number of strategies available to the patient. It is a new kind
of medicine that shifts the experience for both patient and
provider (page 148)” [24].
Some have described Integrative Health Care as a trans-
formative process [9, 25]. Mulkins’s and Verhoef’s study
to identify factors for those patients who seek Integrative
Health Care found 4 dimensions of transformation: (1)
having access to a range of appropriate therapies to support
individual journeys, (2) care that focuses on one’s overall
well being, (3) control over disease management, and
(4) developing healing relationships with care providers
[25]. Bell et al. also deﬁne Integrative Health Care as a
transformative system represented by a higher-order system
of systems of care that emphasizes wellness and healing of
the entire person (bio-psycho-socio-spiritual dimensions)Evidence-Based Complementary and Alternative Medicine 7
Table 4: Descriptive of clinical trials of choice of care (multidimensional) integrative healthcare interventions (n = 7).
Reference Design Sample Trial
duration Intervention Control Primary measures
Evidence
direction
on
primary#
SIGN
score∗
Adverse
events
score
Krucoﬀ et al.
2001 [16]
RCT
150
6m o n t h s M A N T R A U C
DUREL, SSTA, Risk
Stratiﬁcation, and post-PCI
ischemia
Weak ++ 100 Gender: 1 F
Mean Age: 63
Krucoﬀ et al.
2005 [17]
RCT
748
6m o n t h s
MANTRA:
MIT or MIT
plus prayer
UC or
Prayer
DUREL, SSTA, and mood
assessed by VAS before PCI for
unstable coronary syndromes
Weak ++ 100 Gender: 214
F
Mean Age: 65
Seskevich et al.
2004 [18]
RCT
150
15 months MANTRA UC
Mood assessed by VAS before
PCI for unstable coronary
syndromes
Mixed ++ 0 Gender: 1 F
Mean Age: 64
Edelman et al.
2006 [19]
RCT
154
10 months PHP UC 10-year risk of CHD (FRS) Strong + 0 Gender: 81 F
Mean Age: 53
Carlsson et al.
2001 [20]
CCT
120
1 year ABCW CBCW Life satisfaction (EORTC
QLQ-C30, LSQ & MAC) Weak NA 100 Gender: F
Mean Age: 49
Carlsson et al.
2004 [21]
CCT
60 6m o n t h s
plus
follow-up
ABCW CBCW Life satisfaction (EORTC
QLQ-C30 & LSQ) Strong NA 100 Gender: F
Mean Age: 49
Abbreviations: ABCW: Women with breast cancer, anthroposophic therapy; CBCW: Women with breast cancer, conventional therapy; CHC: Coronary heart
disease; DUREL: Duke University religion index; EORTC QLQ-C30: European organization for research and treatment of cancer, quality of life questionnaire
core 30; FRS: Framingham risk score; LSQ: Life satisfaction questionnaire; MAC: Mental adjustment to cancer scale; MANTRA: Monitoring & actualization
of noetic training; MIT: Music, imagery, and touch; PCI: percutaneous coronary intervention; PHP: Personalized health planning; SMT: Spinal manipulative
therapy; SSTA: Spielberger state-trait anxiety inventory; U: Unknown; UC: Usual care; and VAS: Visual analog scale.
#Evidence direction on primary measures. Weak: no outcome measures positive despite suﬃcient statistical power to do so, Mixed: at least one primary
outcome measure positive at the level of P<. 05, Strong ≥ 50% of measures positive at the level of P<. 05, and Inconclusive: study failed to demonstrate a
change but lacked the statistical power to demonstrate.
∗SIGN checklist for RCTs and controlled clinical trials
++: Strong. All or most of the criteria have been fulﬁlled.
+: Article is neither exceptionally strong nor exceptionally weak.
−: Weak. Few or no criteria fulﬁlled.
as primary goals, drawing on best both conventional and
CAM approaches in the context of a supportive and eﬀective
physician-patient relationship [9]. While other proposed a
continuum for team-oriented health care practice starting
from the nonintegrative to fully integrative approach [26].
Therefore, to date no consensus has emerged about what
constitutes Integrative Health Care. While there have been
attempts to create outcome measures for Integrative Health
Care (i.e., one-item visual analogue Arizona Integrative
Outcomes Scale (AIOS), which assesses self-rated global
sense of spiritual, social, mental, emotional, and physical
well-being over the past 24 hours and the past month)
[27] and there has been discussion on the importance of
patient’s perspective on integrative health care outcomes
(i.e., physical well-being, change in physiological indicators,
improved emotional well-being, personal transformation,
feeling connected, global state of well-being, and cure)
[10] none about what the important outcome variables
are that must be measured. A growing body of literature
documents the patient-based outcome assessment (PBOA)
instruments that have been used to determine outcomes in
CAM research to help practitioners and researchers make
informed evidence-based decisions [28, 29]. However, we
were unable to indentify similar literature for Integrative
Health Care. Thus, the claimed inherent holistic nature of
Integrative Health Care in which the social, psychological,
spiritual, physical, and behavioral components oriented
towards support and the stimulation of healing and the
achievement of wholeness (i.e., the whole system) present
special challenges with respect to design of clinical studies
and especially with respect to the calculation of a total eﬀect
size. For this paper, we only reviewed clinical studies that
involved a blending of both CAM and conventional therapy
that provides a seamless continuum of decision-making and
patient-centered care and support. However, heterogeneity
across studies made it impossible to assess a total eﬀect size.
The lack of trials might reﬂect the fact that for the most
part the studies are of already existing programs in which
it is not possible to set up controlled trials. Researchers
here are for the most part studying programs that are8 Evidence-Based Complementary and Alternative Medicine
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already up and running so that the best that can be done is
observational studies [30]. The most common situation for
program evaluation is for existing programs so that we are
comparing (often retrospectively) outcomes before and after
implementation of the program [31].
Lastly, the lack for trial might also reﬂect that controlled
trials may be an inappropriate research model here and that
what are required are methods for whole systems research.
“Thus, unlike biomedical research that typically examines
parts of health care and parts of the individual, one at a time,
but not the complete system, integrative outcomes research
advocates the study of the whole. The whole system includes
the patient-provider relationship, multiple conventional and
CAM treatments, and the philosophical context of care as
the intervention. The systemic outcomes encompass the
simultaneous, interactive changes within the whole person
(page 133)” [9].
Integrative Health care clearly involves, even allowing for
diﬀerences in deﬁnition, the bringing together of diﬀering
complex systems of care [32]. By their very nature, they are
not systems that lend themselves very readily to the type of
research design required for controlled trials.
In spite of the nascent state of integrative health care
research on clinical trials, clinicians may be able to use
this literature review as a guideline for incorporating spe-
ciﬁc types of integrative health practices that are strongly
evidence-based. There is still insuﬃcient evidence to draw
deﬁnite conclusions about the eﬃcacy of integrative health
care treatments; however, they appear to be generally safe.
Available data suggest that some integrative health care
therapies may warrant further study.
8. Limitations/ChallengesEncounteredin
R evie wingtheFieldo fI nt egrati v e
Health Care
Itwasourgoaltoidentifyonlypublishedstudieshavingtodo
with integrative health care. During the initial examination
of key term and primary studies in this paper it was
discovered that there was no clear terminology or deﬁnition
for integrative health care. This lack of clarity made it
diﬃcult to generate search terms for the paper. For example,
IMcanturnupunderintegratedversusintegrativemedicine,
integrated health systems versus holistic health systems. It
might also appear under such things as traditional Chinese
medicine and western medicine. To make sure we captured
all these, the search terms by necessity had to be very broad.
The downside of this strategy was that the search generated
11,891 total citations. Much additional work was required,
therefore, to insure that the studies were truly focused on
integrative health care. This has resulted in a level of review
that is not usual when reviewing citations for inclusion.
Further limitations included: (1) only studies in the English
language were reviewed (2) both peer reviewed and nonpeer
reviewed studies were reviewed. Nonpeer reviewed journals
are generally considered of being lower quality.
The two major limitations however are that we focused
on clinical studies and only those that can be termed
integrative health care as deﬁned here. As noted earlier, this
excluded most of the ﬁeld. However, it is important to show
that in the case of the strongest designs (i.e., RCTs and CCTs)
and were it really is integrative, the ﬁeld at the moment is
very small.
9. Conclusions
There is still insuﬃcient evidence from trials to strongly
support the higher eﬃcacy of integrative medicine regimen
compared with usual care. However, integrative health
care regimen appears to be generally safe. Additional high
quality RCTs and CCTs are therefore needed to build a
stronger evidence-based body of knowledge. This is the same
recommendation that has been made for CAM [33].
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